These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 17143008

  • 1. Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats.
    Tsubouchi R, Hayashi S, Aoi Y, Nishio H, Terashima S, Kato S, Takeuchi K.
    Digestion; 2006; 74(2):91-100. PubMed ID: 17143008
    [Abstract] [Full Text] [Related]

  • 2. Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats.
    Okayama M, Hayashi S, Aoi Y, Nishio H, Kato S, Takeuchi K.
    Dig Dis Sci; 2007 Sep; 52(9):2095-103. PubMed ID: 17429720
    [Abstract] [Full Text] [Related]

  • 3. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice.
    Martín AR, Villegas I, Alarcón de la Lastra C.
    Inflamm Res; 2005 Apr; 54(4):145-51. PubMed ID: 15883736
    [Abstract] [Full Text] [Related]

  • 4. Roles of nitric oxide (NO) and NO synthases in healing of dextran sulfate sodium-induced rat colitis.
    Aoi Y, Terashima S, Ogura M, Nishio H, Kato S, Takeuchi K.
    J Physiol Pharmacol; 2008 Jun; 59(2):315-36. PubMed ID: 18622048
    [Abstract] [Full Text] [Related]

  • 5. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M, Hayashi Y, Yamato M, Murakami M, Takeuchi K.
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [Abstract] [Full Text] [Related]

  • 6. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.
    Hatazawa R, Ohno R, Tanigami M, Tanaka A, Takeuchi K.
    J Pharmacol Exp Ther; 2006 Aug; 318(2):691-9. PubMed ID: 16699067
    [Abstract] [Full Text] [Related]

  • 7. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
    Zwolinska-Wcislo M, Krzysiek-Maczka G, Ptak-Belowska A, Karczewska E, Pajdo R, Sliwowski Z, Urbanczyk K, Drozdowicz D, Konturek SJ, Pawlik WW, Brzozowski T.
    J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
    [Abstract] [Full Text] [Related]

  • 8. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A, Hase S, Miyazawa T, Ohno R, Takeuchi K.
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
    Tanaka K, Suemasu S, Ishihara T, Tasaka Y, Arai Y, Mizushima T.
    Eur J Pharmacol; 2009 Jan 28; 603(1-3):120-32. PubMed ID: 19101538
    [Abstract] [Full Text] [Related]

  • 10. Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.
    Colucci R, Antonioli L, Bernardini N, Ippolito C, Segnani C, Awwad O, Tuccori M, Blandizzi C, Scarpignato C, Fornai M.
    J Pharmacol Exp Ther; 2012 Jul 28; 342(1):140-9. PubMed ID: 22495067
    [Abstract] [Full Text] [Related]

  • 11. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 12. Aggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats.
    Singh VP, Patil CS, Jain NK, Kulkarni SK.
    Pharmacology; 2004 Oct 01; 72(2):77-84. PubMed ID: 15331912
    [Abstract] [Full Text] [Related]

  • 13. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.
    Reuter BK, Asfaha S, Buret A, Sharkey KA, Wallace JL.
    J Clin Invest; 1996 Nov 01; 98(9):2076-85. PubMed ID: 8903327
    [Abstract] [Full Text] [Related]

  • 14. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
    Naito Y, Katada K, Takagi T, Tsuboi H, Isozaki Y, Handa O, Kokura S, Yoshida N, Ichikawa H, Yoshikawa T.
    Int J Mol Med; 2006 Jun 01; 17(6):997-1004. PubMed ID: 16685407
    [Abstract] [Full Text] [Related]

  • 15. Dual role of endogenous nitric oxide in development of dextran sodium sulfate-induced colitis in rats.
    Rumi G, Tsubouchi R, Nishio H, Kato S, Mózsik G, Takeuchi K.
    J Physiol Pharmacol; 2004 Dec 01; 55(4):823-36. PubMed ID: 15613746
    [Abstract] [Full Text] [Related]

  • 16. Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation.
    Fornai M, Blandizzi C, Antonioli L, Colucci R, Bernardini N, Segnani C, De Ponti F, Del Tacca M.
    J Pharmacol Exp Ther; 2006 Jun 01; 317(3):938-45. PubMed ID: 16474005
    [Abstract] [Full Text] [Related]

  • 17. Possible role of mucosal mast cells in the recovery process of colitis induced by dextran sulfate sodium in rats.
    Iba Y, Sugimoto Y, Kamei C, Masukawa T.
    Int Immunopharmacol; 2003 Apr 01; 3(4):485-91. PubMed ID: 12689654
    [Abstract] [Full Text] [Related]

  • 18. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
    Brzozowski T, Konturek PC, Konturek SJ, Pajdo R, Schuppan D, Drozdowicz D, Ptak A, Pawlik M, Nakamura T, Hahn EG.
    J Physiol Pharmacol; 2000 Dec 01; 51(4 Pt 1):751-73. PubMed ID: 11192947
    [Abstract] [Full Text] [Related]

  • 19. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice.
    Naito Y, Takagi T, Kuroda M, Katada K, Ichikawa H, Kokura S, Yoshida N, Okanoue T, Yoshikawa T.
    Inflamm Res; 2004 Sep 01; 53(9):462-8. PubMed ID: 15550999
    [Abstract] [Full Text] [Related]

  • 20. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
    Kato S, Ogawa Y, Kanatsu K, Okayama M, Watanabe T, Arakawa T, Takeuchi K.
    J Pharmacol Exp Ther; 2002 Nov 01; 303(2):503-9. PubMed ID: 12388629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.